edison tv
Metals & Mining
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Associated equity: OpGen
Edison Investment Research has terminated coverage on OpGen (OPGN). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant. Previously published reports can still be accessed via our website.
OpGen — 5 videos in collection
This interactive webinar with OpGen’s CEO Oliver Schacht, CFO Tim Dec and COO Johannes Bacher highlights recent progress in the fight against Antimicrobial Resistance. The presentation includes updates on R&D progress, FDA and NMPA regulatory reviews and pending approvals, upcoming clinical trials, and business development and partnering opportunities. The speakers also comment on key corporate development topics around the shareholder support required to authorise new shares for future strategic development and financing.
Get access to the very latest content matched to your personal investment style.